[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340968-105":59,"doc-detail-340968-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","neutrophil-extracellular-traps-induced-by-chemotherapy-inhibit-tumor-growth-in-murine-models-of-colorectal-cancer","Neutrophil extracellular traps induced by chemotherapy inhibit tumor growth in murine models of colorectal cancer","","Neutrophil extracellular traps (NETs), web-like chromatin-protein structures, can kill pathogens and damage tissues, but their impact on cancer remained unclear. A combined treatment with the glutaminase inhibitor CB-839 and 5-FU suppressed growth of PIK3CA-mutant colorectal cancers across multiple mouse models, with reduced efficacy when NETs were disrupted by DNase I or neutrophil depletion. NETs were detected in tumor biopsies from a phase II clinical trial, and higher NET levels correlated with improved progression-free survival. Mechanistically, the drug combination increased IL-8, recruited neutrophils, elevated neutrophil ROS, induced NET formation, and enabled NET-associated Cathepsin G to enter tumor cells and trigger apoptosis via 14-3-3 cleavage and BAX release.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/neutrophil-extracellular-traps-induced-by-chemotherapy-inhibit-tumor-growth-in-murine-models-of-colorectal-cancer/340968/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/neutrophil-extracellular-traps-induced-by-chemotherapy-inhibit-tumor-growth-in-murine-models-of-colorectal-cancer/340968.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How does the CB-839 and 5-FU combination affect PIK3CA-mutant colorectal cancer growth in mice?","Question",{"text":113,"@type":114},"The combination inhibited tumor growth in xenograft, syngeneic, and genetically engineered mouse models of PIK3CA-mutant colorectal cancer. Disrupting NETs or depleting neutrophils attenuated the treatment efficacy.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What clinical trial evidence links NETs to patient outcomes with this drug combination?",{"text":118,"@type":114},"In a phase II trial, NETs were present in tumor biopsies from patients treated with the CB-839 plus 5-FU combination. Increased NET levels in tumors were associated with longer progression-free survival.",{"name":120,"@type":111,"acceptedAnswer":121},"What mechanism explains how chemotherapy-induced NETs kill colorectal cancer cells?",{"text":122,"@type":114},"The combination induced NET formation by increasing IL-8-driven neutrophil recruitment and elevating neutrophil ROS. NET-associated Cathepsin G enters colorectal cancer cells through RAGE, cleaves 14-3-3 proteins, releases BAX, and triggers apoptosis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},340968,1790873411,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":19,"preview_urls":145},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","The Journal of Clinical Investigation RESEAR CH ARTICLE  \nNeutrophil extracellular traps induced by chemotherapy inhibit tumor growth in murine models of colorectal cancer  \nYamu Li,1,2 Sulin Wu,1,3,4 Yiqing Zhao,1,2 Trang Dinh,1,2 Dongxu Jiang,1,2 J. Eva Selfridge,1,2,3,5 George Myers,6 Yuxiang Wang,1,2 Xuan Zhao,1,2 Suzanne Tomchuck,7 George Dubyak,8 Richard T. Lee,3,5 Bassam Estfan,9 Marc Shapiro,9 Suneel Kamath,9 Amr Mohamed,3,5 Stanley Ching-Cheng Huang,2,6 Alex Y. Huang,7 Ronald Conlon,1 Smitha Krishnamurthi,9 Jennifer Eads,3,5,10 Joseph E. Willis,6 Alok A. Khorana,9 David Bajor,3,5 and Zhenghe Wang1,2  \n1Department of Genetics and Genome Sciences, 2Case Comprehensive Cancer Center, 3Department of Internal Medicine, 4Department of Medical Genetics, Case Western Reserve University, Cleveland, Ohio. USA. 5Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.6Department of Pathology, 7Department of Pediatrics, and 8Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio. USA. 9Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA. 10Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.  \nNeutrophil extracellular traps (NETs), a web-like structure of cytosolic and granule proteins assembled on decondensed chromatin, kill pathogens and cause tissue damage in diseases. Whether NETs can kill cancer cells is unexplored. Here, we report that a combination of glutaminase inhibitor CB-839 and 5-FU inhibited the growth of PIK3CA-mutant colorectal cancers (CRCs) in xenograft, syngeneic, and genetically engineered mouse models in part through NETs. Disruption of NETs by either DNase I treatment or depletion of neutrophils in CRCs attenuated the efficacy of the drug combination. Moreover, NETs were present in tumor biopsies from patients treated with the drug combination in a phase II clinical trial. Increased NET levels in tumors were associated with longer progression-free survival. Mechanistically, the drug combination induced the expression of IL-8 preferentially in PIK3CA-mutant CRCs to attract neutrophils into the tumors. Further, the drug combination increased the levels of ROS in neutrophils, thereby inducing NETs. Cathepsin G (CTSG), a serine protease localized in NETs, entered CRC cells through the RAGE cell surface protein. The internalized CTSG cleaved 14-3-3 proteins, released BAX, and triggered apoptosis in CRC cells. Thus, our studies illuminate a previously unrecognized mechanism by which chemotherapy-induced NETs kill cancer cells.  \nIntroduction  \nNeutrophils are the most abundant leukocytes in peripheral blood and play a vital role in host defenses against pathogens (1). Neutrophils kill pathogens, including bacteria and fungi, by phagocytosis and by releasing granular enzymes and ROS (1). It was first discovered in 2004 that neutrophils could trap and kill bacteria by releasing Neutrophil extracellular traps (NETs), which consist of decondensed chromatin, granular enzymes, and cytosolic proteins to form web-like structures (2). NET release occurs primarily through a cell death pathway called netosis (1) . In the netosis process, nuclear envelopes are dissembled, histones are citrullinated by protein-arginine deiminase 4 (PAD4), which leads to chromatin decondensation, plasma membranes are ruptured, and NETs are  \nRelated Commentary: [https://doi.org/10.1172/JCI178344](https://doi.org/10.1172/JCI178344)  \nConflict of interest: JE reports spousal employment from Bristol Meyes Squibband Janssen. JE consults and advises for and Merck. JE has received research support from Amgen, Merck, Seagen, Hutchmed, Gilead, Genentech, AstraZeneca, Oncolys, and Arcus.  \nCopyright: © 2024, Li et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.  \nSubmitted: August 22, 2023; Accepted: January 5, 2024; Published: January 9, 2024.  \nReference informatio","cbCaijGnLWVSR5jY","https://ap.wps.com/l/cbCaijGnLWVSR5jY","pdf",9025427,"English","# Introduction\n## Neutrophils and NET formation\n## NETs in cancer and colorectal cancer relevance\n# Results","[{\"question\":\"How does the CB-839 and 5-FU combination affect PIK3CA-mutant colorectal cancer growth in mice?\",\"answer\":\"The combination inhibited tumor growth in xenograft, syngeneic, and genetically engineered mouse models of PIK3CA-mutant colorectal cancer. Disrupting NETs or depleting neutrophils attenuated the treatment efficacy.\"},{\"question\":\"What clinical trial evidence links NETs to patient outcomes with this drug combination?\",\"answer\":\"In a phase II trial, NETs were present in tumor biopsies from patients treated with the CB-839 plus 5-FU combination. Increased NET levels in tumors were associated with longer progression-free survival.\"},{\"question\":\"What mechanism explains how chemotherapy-induced NETs kill colorectal cancer cells?\",\"answer\":\"The combination induced NET formation by increasing IL-8-driven neutrophil recruitment and elevating neutrophil ROS. NET-associated Cathepsin G enters colorectal cancer cells through RAGE, cleaves 14-3-3 proteins, releases BAX, and triggers apoptosis.\"}]","Neutrophil extracellular traps induced by chemotherapy inhibit tumor growth in murine models of colorectal cancer | PDF",1790039734,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/535b577831a13de7cfeff0eb640b9a76.webp",983,1315,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d032e76dfecba7e3081c097e8053d54d.webp",982,1314,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5adb02c650160ce514b8cd354df959b6.webp",981,1312,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a908af1af56474879fee3fd1366cc05.webp",980,1311]